Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Pacira Pharmaceuticals buy Wedbush

Pacira Pharmaceuticals
Start price
€25.80
08.02.24 / 50%
Target price
€53.03
08.02.25
Performance (%)
-0.78%
End price
€25.60
09.02.25
Summary
This prediction ended on 09.02.25 with a price of €25.60. During the runtime of the prediction for Pacira Pharmaceuticals the price only changed by -0.78%. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Pacira Pharmaceuticals 0.000% 0.000% -7.692%
iShares Core DAX® 0.985% 8.314% 7.032%
iShares Nasdaq 100 2.067% 16.765% 35.952%
iShares Nikkei 225® 2.270% 15.605% 46.568%
iShares S&P 500 1.043% 11.077% 26.456%

Comments by Wedbush for this prediction

In the thread Pacira Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -0.78%
Target price 53.033
Change
Ends at 08.02.25

Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat

Wedbush 
0
Report Share
08.02.24
In the thread Trading Pacira Pharmaceuticals
Prediction Buy
Perf. (%) -0.78%
Target price 53.033
Change
Ends at 08.02.25

Die von Wedbush gewählte maximale Laufzeit wurde überschritten

Wedbush 
0
Report Share
09.02.25